Insider trading · Q3 2026 · CIK 8818

Avery Dennison Corp (AVY) insider trading.

In Q3 2026, insiders at Avery Dennison Corp reported 5 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $962K.

Transactions
5
Purchases (P)
0
Sales (S)
2
Net shares, P minus S
-5,628
Insiders
4
Last filed
2026-09-16

Insiders

InsiderRelationshipTransactionsBuysSales
Butier Mitchell RDirector200
Colisto NicholasOfficer · SVP & CIO101
Walker Ignacio JOfficer · SVP and Chief Legal Officer101
Flitman David EDirector100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-15Colisto NicholasS (D)3,886$170.687,126Form 4
2026-08-14Butier Mitchell RI (D)2,185$178.930Form 4
2026-08-13Butier Mitchell RI (D)2,185$180.012,185Form 4
2026-08-04Walker Ignacio JS (D)1,742$171.617,585Form 4
2026-07-23Flitman David EM (A)765$156.11765Form 4

Transaction codes in this quarter

Get AVY insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=8818&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AVY company page · Avery Dennison Corp on SEC.gov

Questions

Are insiders buying or selling Avery Dennison Corp (AVY)?

In Q3 2026, insiders at Avery Dennison Corp reported 5 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $962K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Avery Dennison Corp insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/avy.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.